Impact Factor

The Society is very proud to announce the 2019 impact factor (4.113) for the Journal of Neuroimmune Pharmacology, our official journal.

This is an outstanding accomplishment for Editor-in-Chief Dr. Howard E. Gendelman, the editorial board and the society. JNIP has matched or exceeded the median impact of its peer journals in immunology, neuroscience, pharmacology and infectious diseases, many that have been published for decades. The increase is a testament to the outstanding articles being published in the journal and also that others in our field are turning to JNIP as their resource for current information.

We hope you will continue to submit your work to JNIP, encourage your colleagues to submit and also reference published articles.

Thank you for supporting the Society on NeuroImmune Pharmacology and the Journal of Neuroimmune Pharmacology.